Journal of Extracellular Vesicles (Feb 2024)

Lipid profile of circulating placental extracellular vesicles during pregnancy identifies foetal growth restriction risk

  • Miira M. Klemetti,
  • Ante B. V. Pettersson,
  • Aafaque Ahmad Khan,
  • Leonardo Ermini,
  • Tyler R. Porter,
  • Michael L. Litvack,
  • Sruthi Alahari,
  • Stacy Zamudio,
  • Nicholas P. Illsley,
  • Hannes Röst,
  • Martin Post,
  • Isabella Caniggia

DOI
https://doi.org/10.1002/jev2.12413
Journal volume & issue
Vol. 13, no. 2
pp. n/a – n/a

Abstract

Read online

Abstract Small‐for‐gestational age (SGA) neonates exhibit increased perinatal morbidity and mortality, and a greater risk of developing chronic diseases in adulthood. Currently, no effective maternal blood‐based screening methods for determining SGA risk are available. We used a high‐resolution MS/MSALL shotgun lipidomic approach to explore the lipid profiles of small extracellular vesicles (sEV) released from the placenta into the circulation of pregnant individuals. Samples were acquired from 195 normal and 41 SGA pregnancies. Lipid profiles were determined serially across pregnancy. We identified specific lipid signatures of placental sEVs that define the trajectory of a normal pregnancy and their changes occurring in relation to maternal characteristics (parity and ethnicity) and birthweight centile. We constructed a multivariate model demonstrating that specific lipid features of circulating placental sEVs, particularly during early gestation, are highly predictive of SGA infants. Lipidomic‐based biomarker development promises to improve the early detection of pregnancies at risk of developing SGA, an unmet clinical need in obstetrics.

Keywords